                         SEQUENCE LISTING

<110>  Nepenthe Biosciences LLC
 
<120>  Anti-CD79 Antibodies and Their Uses

<130>  PRI.0012

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycosylation site

<220>
<221>  X
<222>  (2)..(2)
<223>  X=any amino acid except Pro

<400>  1

Asn Xaa Ser 
1           


<210>  2
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycosylation site


<220>
<221>  X
<222>  (2)..(2)
<223>  X=any amino acid except Pro

<400>  2

Asn Xaa Thr 
1           


